University of Cambridge
310
56
76
135
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
3.5%
11 terminated/withdrawn out of 310 trials
92.5%
+5.9% vs industry average
8%
26 trials in Phase 3/4
12%
16 of 135 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (310)
A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin
Role: collaborator
WIRE - Novel Treatments in Renal Cell Cancer
Role: collaborator
Identifying the Best Tools for Recording Diet in Free-living UK Adults (SODIAT-2 Study)
Role: collaborator
Controlled Oxygen Desaturation Study of the Neonatal Wireless Transmission System
Role: collaborator
Adding Male Single Dose HPV Vaccination to Female HPV Vaccination in Tanzania
Role: collaborator
Understanding Patterns of Fatigue in Health and Disease
Role: collaborator
An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM
Role: collaborator
The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions
Role: lead
How the Brain and Body Recover After a Wrist Fracture
Role: collaborator
5G-EMERALD: Amivantamab in Malignant Brain Tumours
Role: collaborator
Pulmonary Hypertension: Intensification and Personalisation of Combination Rx
Role: collaborator
Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling
Role: collaborator
An Experimental Study of Belzutifan Impact on Catecholamine Metabolism
Role: collaborator
Electronic Cardiac Rehabilitation (eCardiacRehab) Feasibility Study
Role: collaborator
eCardiacRehab - a Hybrid Patient-Centered eHealth Programme
Role: collaborator
A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease
Role: collaborator
MNGIE Natural History Study
Role: lead
AGILE (Early Phase Platform Trial for COVID-19)
Role: collaborator
Mechanism of Chronic Pain in Patients With IBD
Role: collaborator
IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2
Role: lead